The impact of sleeve gastrectomy on recurrent obese hyperlipidemic pancreatitis

VernacularTitle:袖状胃切除术对反复发作肥胖型急性高脂血症性胰腺炎的疗效
Author: Guogang WU ¹ ; Minghui WANG ; Jing SHEN ; Zhaorun LIU ; Mei LENG ; Jisheng LIU ; Min FU
Author Information

1. 鞍钢集团总医院普通外科
Keywords: Hyperlipidemic acute pancreatitis (HLAP); Obese; Sleeve gastrectomy (LSG)
From: Chinese Journal of Hepatobiliary Surgery 2018;24(12):829-832
CountryChina
Language:Chinese
Abstract: Objective To study the impact of weight loss surgery after 3 months of stable condition through intervention on patients with obese hyperlipidemic acute pancreatitis (HLAP).Methods Ten patients with obese HLAP who underwent laparoscopic sleeve gastrectomy (LSG) at the General Surgery Department of our hospital were followed-up at 1,3,6,12,24 months after surgery.Their weight,BMI,EWL,and blood parameters (TG,LDL-C,HDL-C,TC,FPG,HbA1c,UA,hs-CRP,ESR,and hemorheology indexes) were compared.The impact on postoperative obese HLAP was assessed.Results The weight,BMI,EWL and blood index (TG,LDL-C,HDL-C,TC,FPG,HbA1c,UA,hs-CRP,ESR,and hemorheology indexes) of the patients gradually decreased.The decrease was significantly different from that before surgery (P＜0.05),which became stable at 12 months and with no recurrence at 24 months after surgery.Conclusions LSG reduced body weight and improved metabolic status of the patients.It stopped the occurrence of obese HLAP.LSG can be used as an effective intervention for patients with obese HLAP.